Apalutamide and Goserelin for Androgen Receptor-Positive Salivary Gland Carcinoma: A Phase II Nonrandomized Clinical Trial, YATAGARASU.
Honma Y, Monden N, Yamazaki K, Kano S, Satake H, Kadowaki S, Utsumi Y, Nakatogawa T, Takano R, Fujii K, Koroki Y, Aoyama J, Ouchi S, Ogawa T, McCarthy S, Brookman-May SD, Mundle S, Li J, Thaper D, Nagao T, Tada Y.
Honma Y, et al. Among authors: nakatogawa t.
Clin Cancer Res. 2024 Aug 15;30(16):3416-3427. doi: 10.1158/1078-0432.CCR-24-0455.
Clin Cancer Res. 2024.
PMID: 38940667
Clinical Trial.